AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1558571 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated patients (N = 13)
Number of subjects: 112
Study 1558571 — intervention group
Group type: COMPARATOR
Intervention: Control children
Number of subjects: 112
Study 3937005 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infusion
Number of subjects: 40
Study 3937005 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocainide infusion
Number of subjects: 40
Study 3937005 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tocainide therapy
Number of subjects: 40
Study 3937005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31562496 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0% NaCl (hypertonic)
Number of subjects: 60
Study 31562496 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (isotonic)
Number of subjects: 60
Study 30761795 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel (Androgel) at a daily dose of 5 g (1 sachet)
Number of subjects: 90
Study 30761795 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel (Androgel) at a daily dose of 10 g (2 sachets)
Number of subjects: 90
Study 30761795 — intervention group
Group type: COMPARATOR
Intervention: Basic therapy (exercise, diet, multivitamins)
Number of subjects: 90
Study 27571129 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cytarabine with systemic dexamethasone
Number of subjects: 40
Study 27571129 — intervention group
Group type: COMPARATOR
Intervention: Triple intrathecal therapy (TIT)
Number of subjects: 40
Study 27571129 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cytarabine
Number of subjects: 40
Study 24121146 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprazole 10 mg/day
Number of subjects: 268
Study 24121146 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprazole 5 mg
Number of subjects: 268
Study 24121146 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprazole 10 mg
Number of subjects: 268
Study 24121146 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 268
Study 22493910 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep puncturing group (32 cases)
Number of subjects: 63
Study 22493910 — intervention group
Group type: COMPARATOR
Intervention: Shallow puncturing group (31 cases)
Number of subjects: 63
Study 22493910 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 63
Study 20537753 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-mm covered stent
Number of subjects: 45
Study 20537753 — intervention group
Group type: COMPARATOR
Intervention: 10-mm covered stent
Number of subjects: 45
Study 18501262 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief interpersonal psychotherapy
Number of subjects: 257
Study 18501262 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg daily of the SSRI antidepressant paroxetine
Number of subjects: 257
Study 18501262 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 257
Study 15680142 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency words
Number of subjects: 0
Study 15680142 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency words
Number of subjects: 0
Study 15680142 — intervention group
Group type: EXPERIMENTAL
Intervention: High phonotactic frequency nonwords
Number of subjects: 0
Study 15680142 — intervention group
Group type: EXPERIMENTAL
Intervention: Low phonotactic frequency nonwords
Number of subjects: 0
Study 15680142 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolingual group
Number of subjects: 0
Study 15680142 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilingual group
Number of subjects: 0
Study 15680142 — intervention group
Group type: EXPERIMENTAL
Intervention: Language familiarity
Number of subjects: 0
Study 12752560 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling until exhaustion on a bicycle ergometer
Number of subjects: 81
Study 10475292 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 2.5 mg i.v. and glycopyrrolate 0.5 mg i.v. for reversal of residual neuromuscular blockade
Number of subjects: 100
Study 10475292 — intervention group
Group type: COMPARATOR
Intervention: No neostigmine administration
Number of subjects: 100
Study 8542854 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine plus buprenorphine (7.2 mg kg‐1 of buprenorphine with 1.8 mg kg‐1 of bupivacaine)
Number of subjects: 30
Study 8542854 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine plus buprenorphine
Number of subjects: 30
Study 8542854 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine alone (1.8 mg kg‐1)
Number of subjects: 30
Study 8542854 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine alone
Number of subjects: 30
Study 2014357 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage (PD) and forced expiration technique (FET)
Number of subjects: 9
Study 2014357 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage (PD) and forced expiration technique (FET) with fast percussion
Number of subjects: 9
Study 2014357 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage (PD) and forced expiration technique (FET) with slow percussion
Number of subjects: 9
Study 7026018 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 55
Study 7026018 — intervention group
Group type: COMPARATOR
Intervention: Control (no levamisole)
Number of subjects: 55
Study 31073880 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Search Training (PST)
Number of subjects: 303
Study 31073880 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioural Intervention (CBI)
Number of subjects: 303
Study 31073880 — intervention group
Group type: COMPARATOR
Intervention: Curriculum-as-Usual (CAU)
Number of subjects: 303
Study 31073880 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive Symptoms
Number of subjects: 303
Study 28481967 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus bevacizumab at randomization
Number of subjects: 361
Study 28481967 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy followed by bevacizumab after disease progression (PD)
Number of subjects: 361
Study 28481967 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (control group)
Number of subjects: 361
Study 25721074 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 37
Study 25721074 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 37
Study 22563991 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion activities (intervention)
Number of subjects: 1675
Study 22563991 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1675
Study 21282542 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib 300 mg/d
Number of subjects: 1240
Study 21282542 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib 150 mg/d
Number of subjects: 1240
Study 19329464 — intervention group
Group type: EXPERIMENTAL
Intervention: Compomer restorations
Number of subjects: 534
Study 19329464 — intervention group
Group type: COMPARATOR
Intervention: Amalgam restorations
Number of subjects: 534
Study 16899475 — intervention group
Group type: EXPERIMENTAL
Intervention: oral oestradiol‐17beta 1 mg plus norethisterone acetate 0.5 mg daily
Number of subjects: 100
Study 16899475 — intervention group
Group type: COMPARATOR
Intervention: matching placebo
Number of subjects: 100
Study 14976888 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of clomiphene and Chinese drugs for nourishing Shen and activating blood circulation (NSABC)
Number of subjects: 62
Study 14976888 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene alone (Control)
Number of subjects: 62
Study 11182704 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 18
Study 11182704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9429989 — intervention group
Group type: EXPERIMENTAL
Intervention: apoE3/2 or apoE3/3
Number of subjects: 28
Study 9429989 — intervention group
Group type: COMPARATOR
Intervention: apoE4/2, apoE4/3, or apoE4/4
Number of subjects: 28
Study 9429989 — intervention group
Group type: EXPERIMENTAL
Intervention: apoE3/2 and apoE3/3
Number of subjects: 28
Study 7636533 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin 30 mg/d for 6 months
Number of subjects: 44
Study 7636533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 2693439 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (25 patients)
Number of subjects: 40
Study 2693439 — intervention group
Group type: COMPARATOR
Intervention: Control group (15 patients, not given dexamethasone)
Number of subjects: 40
Study 2693439 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone vs No Dexamethasone
Number of subjects: 40
Study 701217 — intervention group
Group type: EXPERIMENTAL
Intervention: System A - cash prize drawings of $20 for no absenteeism during a 3-week period
Number of subjects: 92
Study 701217 — intervention group
Group type: EXPERIMENTAL
Intervention: System B - cash prize drawings of $20 for not being absent on eight randomly selected dates from the 3-week period
Number of subjects: 92
Study 701217 — intervention group
Group type: COMPARATOR
Intervention: Both reward systems
Number of subjects: 92
Study 701217 — intervention group
Group type: COMPARATOR
Intervention: Income level
Number of subjects: 92
Study 31350938 — intervention group
Group type: EXPERIMENTAL
Intervention: Hochu-ekki-to (HET) 7.5 g oral per day, n = 9
Number of subjects: 18
Study 31350938 — intervention group
Group type: COMPARATOR
Intervention: Control group, n = 9
Number of subjects: 18
Study 28379607 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous skin cell suspension plus hydrocolloid dressings
Number of subjects: 106
Study 28379607 — intervention group
Group type: COMPARATOR
Intervention: Hydrocolloid dressings alone
Number of subjects: 106
Study 28379607 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study 28379607 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous skin cell suspension
Number of subjects: 106
Study 25928696 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean dietary pattern (MedDiet) for 6 months
Number of subjects: 166
Study 25928696 — intervention group
Group type: COMPARATOR
Intervention: Customary lifestyle and diet (Control)
Number of subjects: 166
Study 25110222 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (malabsorptive procedure)
Number of subjects: 20
Study 21744377 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (mean 78.7 mg/day)
Number of subjects: 40
Study 21744377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 19330379 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding (EOF)
Number of subjects: 40
Study 19330379 — intervention group
Group type: COMPARATOR
Intervention: Traditional oral feeding (TOF)
Number of subjects: 40
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐administered questionnaire
Number of subjects: 523
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical staff interview
Number of subjects: 523
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician interview
Number of subjects: 523
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: WAST‐Short
Number of subjects: 523
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of domestic violence
Number of subjects: 523
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient comfort with screening
Number of subjects: 523
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician comfort with screening
Number of subjects: 523
Study 17893385 — intervention group
Group type: EXPERIMENTAL
Intervention: Average time spent screening
Number of subjects: 523
Study 14699550 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain used
Number of subjects: 53
Study 14699550 — intervention group
Group type: COMPARATOR
Intervention: No drain used
Number of subjects: 53
Study 11865127 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic criteria of reflex sympathetic dystrophy (RSD)
Number of subjects: 73
Study 11865127 — intervention group
Group type: COMPARATOR
Intervention: Complex regional pain syndrome (CRPS) diagnostic criteria
Number of subjects: 73
Study 9215820 — intervention group
Group type: EXPERIMENTAL
Intervention: Droloxifene (DRO) as first-line hormone therapy (HT)
Number of subjects: 94
Study 8459456 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin (4.5 g, every 6 hours)
Number of subjects: 246
Study 8459456 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (80 mg, every 8 hours) and Metronidazole (500 mg every 6 hours)
Number of subjects: 246
Study 2943309 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 15 mg
Number of subjects: 12
Study 2943309 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 30 mg
Number of subjects: 12
Study 2943309 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 30 mg (morning administration)
Number of subjects: 12
Study 2943309 — intervention group
Group type: COMPARATOR
Intervention: Placebo (bedtime)
Number of subjects: 12
Study 2943309 — intervention group
Group type: COMPARATOR
Intervention: Placebo (morning)
Number of subjects: 12
Study 30035123 — intervention group
Group type: EXPERIMENTAL
Intervention: New material diapers (Group A, n = 41)
Number of subjects: 80
Study 30035123 — intervention group
Group type: COMPARATOR
Intervention: Standard diapers (Group B, n = 39)
Number of subjects: 80
Study 30035123 — intervention group
Group type: EXPERIMENTAL
Intervention: New material diapers (Group A)
Number of subjects: 80
Study 30035123 — intervention group
Group type: COMPARATOR
Intervention: Standard diapers (Group B)
Number of subjects: 80
Study 26711859 — intervention group
Group type: EXPERIMENTAL
Intervention: Stendo Pulsating Suit
Number of subjects: 24
Study 26711859 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 24
Study 25287106 — intervention group
Group type: EXPERIMENTAL
Intervention: PTP-guided ventilation strategy
Number of subjects: 200
Study 25287106 — intervention group
Group type: COMPARATOR
Intervention: High-PEEP control
Number of subjects: 200
Study 22841529 — intervention group
Group type: EXPERIMENTAL
Intervention: Water supplementation
Number of subjects: 168
Study 22841529 — intervention group
Group type: COMPARATOR
Intervention: Control group (no water supplementation)
Number of subjects: 168
Study 20814324 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (8 mg) gum
Number of subjects: 24
Study 20814324 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 24
Study 18048636 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief protocol including booster sessions
Number of subjects: 6322
Study 18048636 — intervention group
Group type: COMPARATOR
Intervention: American Cancer Society's standard protocol with boosters
Number of subjects: 6322
Study 16383035 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of recombinant human growth hormone (rhGH)
Number of subjects: 207
Study 16383035 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous injection of isotonic saline (placebo control)
Number of subjects: 207
Study 11896746 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medication (Potassium bromide 1X, Sodium bromide 2X, Nickel sulfate 3X, Sodium chloride 6X)
Number of subjects: 41
Study 11896746 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 41
Study 10554537 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium and vitamin E as antioxidants in addition to standard therapy
Number of subjects: 0
Study 10554537 — intervention group
Group type: COMPARATOR
Intervention: Reference group with no additional therapy
Number of subjects: 0
Study 7481869 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 2000
Study 7481869 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 2000
Study 7481869 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin and cyclophosphamide
Number of subjects: 2000
Study 7481869 — intervention group
Group type: COMPARATOR
Intervention: Intraperitoneal cisplatin/IV paclitaxel
Number of subjects: 2000
Study 7481869 — intervention group
Group type: COMPARATOR
Intervention: IV paclitaxel/cisplatin regimen
Number of subjects: 2000
Study 7481869 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-intensive regimen incorporating two courses of carboplatin
Number of subjects: 2000
Study 7481869 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose carboplatin/cyclophosphamide/mitoxantrone
Number of subjects: 2000
Study 7481869 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cisplatin/cyclophosphamide/thiotepa
Number of subjects: 2000
Study 2038933 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose epinephrine (5 mg)
Number of subjects: 68
Study 2038933 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose epinephrine (1 mg)
Number of subjects: 68
Study 7462674 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate cream
Number of subjects: 0
Study 7462674 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% beta‐methasone 17‐valerate cream
Number of subjects: 0
Study 7462674 — intervention group
Group type: COMPARATOR
Intervention: cream base
Number of subjects: 0
Study 7462674 — intervention group
Group type: COMPARATOR
Intervention: clobetasone butyrate 0.05% cream
Number of subjects: 0
Study 7462674 — intervention group
Group type: COMPARATOR
Intervention: hydrocortisone 1% cream
Number of subjects: 0
Study 30583108 — intervention group
Group type: EXPERIMENTAL
Intervention: ACD (anterior cervical discectomy)
Number of subjects: 109
Study 30583108 — intervention group
Group type: EXPERIMENTAL
Intervention: ACDF (anterior cervical discectomy and fusion)
Number of subjects: 109
Study 30583108 — intervention group
Group type: EXPERIMENTAL
Intervention: ACDA (anterior cervical disc arthroplasty)
Number of subjects: 109
Study 30583108 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (EQ-5D)
Number of subjects: 109
Study 30583108 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjacent segment degeneration parameters
Number of subjects: 109
Study 27752866 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Physical Activity Internet Intervention
Number of subjects: 205
Study 27752866 — intervention group
Group type: COMPARATOR
Intervention: Wellness Contact Control Internet Group
Number of subjects: 205
Study 26105555 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention (four modules: information exchange website, bulletin board system, individualized online counseling, animation game)
Number of subjects: 202
Study 26105555 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 202
Study 23820460 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan administered via nasogastric tube (crushed tablet in suspension)
Number of subjects: 28
Study 23820460 — intervention group
Group type: COMPARATOR
Intervention: Tolvaptan tablets swallowed intact (oral administration)
Number of subjects: 28
Study 23204686 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg followed by intravaginal misoprostol 600 μg and 400 μg every 3 hours up to 5 doses
Number of subjects: 200
Study 23204686 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone (600 μg followed by 400 μg every 3 hours up to 5 doses)
Number of subjects: 200
Study 19299774 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematocrit of 25% during surgery
Number of subjects: 104
Study 19299774 — intervention group
Group type: COMPARATOR
Intervention: Hematocrit of 35% during surgery
Number of subjects: 104
Study 19299774 — intervention group
Group type: EXPERIMENTAL
Intervention: D-TGA subjects during CPB cooling
Number of subjects: 104
Study 19299774 — intervention group
Group type: EXPERIMENTAL
Intervention: D-TGA subjects with > or =5 min of deep hypothermic circulatory arrest (DHCA)
Number of subjects: 104
Study 17162029 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 231
Study 17162029 — intervention group
Group type: COMPARATOR
Intervention: Placebo/stretching and motion exercises
Number of subjects: 231
Study 15465981 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 269
Study 15465981 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 269
Study 11479249 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting (n=600; diabetic, 112)
Number of subjects: 1205
Study 11479249 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG (n=605; diabetic, 96)
Number of subjects: 1205
Study 11479249 — intervention group
Group type: COMPARATOR
Intervention: Stenting (n=600; nondiabetic)
Number of subjects: 1205
Study 11479249 — intervention group
Group type: COMPARATOR
Intervention: CABG (n=605; nondiabetic)
Number of subjects: 1205
Study 9928923 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine + Paroxetine (20 mg)
Number of subjects: 14
Study 9928923 — intervention group
Group type: COMPARATOR
Intervention: Clozapine (2.5 mg/kg)
Number of subjects: 14
Study 8306217 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP)
Number of subjects: 44
Study 8306217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 2556978 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG treatment (500 mg/kg, 12 weekly infusions)
Number of subjects: 28
Study 2556978 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 28
Study 2556978 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG treatment
Number of subjects: 28
Study 2556978 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study 5811679 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn-oil diet
Number of subjects: 0
Study 5811679 — intervention group
Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 0
Study 31182492 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating (HE)
Number of subjects: 436
Study 31182492 — intervention group
Group type: COMPARATOR
Intervention: No Healthy Eating (No HE)
Number of subjects: 436
Study 31182492 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 436
Study 31182492 — intervention group
Group type: COMPARATOR
Intervention: No Physical Activity (No PA)
Number of subjects: 436